Go Deep
Daiken Medical Co., Ltd.
Daiken Medical Co., Ltd. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,553 | 13.9 | 1.59 | 0.28 | 256.07 |
| Oct 2026 | 22,773 | 13.8 | 1.58 | 0.28 | 253.16 |
| Oct 2026 | 22,796 | 13.8 | 1.57 | 0.28 | 251.37 |
| Oct 2026 | 22,784 | 13.9 | 1.57 | 0.28 | 252.24 |
Daiken Medical Co., Ltd. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,439,835,000.0 | 2,410,077,000.0 | 2,823,199,000.0 | 2,560,236,000.0 |
| Net Profit | 167,414,000.0 | 81,854,000.0 | 328,897,000.0 | 296,378,000.0 |
| EPS | 5.8 | — | — | — |
Daiken Medical Co., Ltd. Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 10,290,984,000.0 | 9,951,701,000.0 | 9,750,166,000.0 | 9,137,102,000.0 |
| Net Profit | 922,641,000.0 | 1,097,620,000.0 | 988,602,000.0 | 712,062,000.0 |
| EPS | 32.1 | 38.2 | 34.4 | 24.8 |
Daiken Medical Co., Ltd. Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 11,366,782,000.0 | 11,181,079,000.0 | 11,006,318,000.0 | 11,013,404,000.0 | — |
| Total Liabilities | 3,589,312,000.0 | 3,665,092,000.0 | 3,983,844,000.0 | 4,416,258,000.0 | — |
| Total Equity | 7,777,470,000.0 | 7,515,987,000.0 | 7,022,474,000.0 | 6,597,146,000.0 | — |
Owes vs Owns
Daiken Medical Co., Ltd. owed ¥0.31 for every ¥1 it owned in Jun 2026, down from ¥0.40 in Mar 2023.
| Period | Jun 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.31× | 0.32× | 0.33× | 0.36× | 0.40× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Daiken Medical Co., Ltd. Assets & Liabilities Breakdown (JPY millions)
What it owns — Mar 2026
Cash & short-term investments 24.4%Receivables 10.8%Inventory 14.0%Fixed assets (tangible) 35.6%Other assets 14.9%
How it's funded — Mar 2026
Short-term debt 12.2%Long-term debt 7.4%Payables 5.0%Other liabilities 7.0%Shareholders' equity 68.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2,778.4 | 2,996.0 | 2,739.1 | 2,516.2 |
| Receivables | 1,231.1 | 1,177.7 | 1,207.3 | 1,300.9 |
| Inventory | 1,591.9 | 1,430.1 | 1,438.0 | 1,514.7 |
| Fixed assets (tangible) | 4,043.8 | 3,931.2 | 3,986.5 | 4,070.2 |
| Intangible assets | 22.6 | 12.9 | 13.5 | 9.4 |
| Long-term investments | 8.8 | 8.8 | 8.8 | 8.8 |
| Other assets | 1,690.1 | 1,624.4 | 1,613.0 | 1,593.2 |
| Liabilities & equity | ||||
| Short-term debt | 1,390.0 | 1,200.0 | 1,478.0 | 1,680.3 |
| Long-term debt | 840.0 | 818.4 | 623.4 | 1,013.4 |
| Payables | 564.6 | 542.9 | 465.6 | 529.2 |
| Other liabilities | 794.6 | 1,103.8 | 1,416.8 | 1,193.4 |
| Shareholders' equity | 7,777.5 | 7,516.0 | 7,022.5 | 6,597.1 |
| Net tangible assets | 7,754.8 | 7,503.1 | 7,009.0 | 6,587.7 |
Daiken Medical Co., Ltd. Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 567,713,000.0 | 1,120,908,000.0 | 1,555,500,000.0 | 989,156,000.0 | — |
| Investing Activities | -330,007,000.0 | -168,046,000.0 | -168,767,000.0 | -210,526,000.0 | — |
| Financing Activities | -455,319,000.0 | -696,009,000.0 | -1,163,804,000.0 | -781,007,000.0 | — |